Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
RGD - 4C
| Overview | |
|---|---|
| Description | This peptide, a double cyclic peptide, binds preferentially to integrins at sites of tumor angiogenesis and inflammed synovium in-vivo, and can be internalized into targeted cells. |
| Sequence | ACDCRGDCFCG (Disulfide bridge: 2-10 and 4-8) |
| Sequence (3 Letter) | H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH (Disulfide bridge: 2-10 and 4-8) |
| Molecular Weight | 1145.3 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Ref: Curnis, F. et al. Cancer Res. 64, 565 (2004); Su, Z. et al. Bioconjug. Chem. 13, 561 (2002); Gerlag, M. et al. Arthritis Res. 3, 357 (2001); Ellerby, H. et al. Nature Med. 5, 1032 (1999);
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.